Riskpilot← Back to searchSign inGet full accessJS-Med AB
ABIn liquidationOrg 5569377004Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2019
SEK 320K
+30% vs 2018
EBITDA margin
15.0%
+250% vs 2018
Equity ratio
32.6%
Financial strength
Net profit 2019
SEK 79K
0 employees
| Revenue | SEK 320K | +30% |
| EBITDA | SEK 48K | +250% |
| Net profit | SEK 79K | — |
| Total assets | SEK 497K | +12% |
| Equity | SEK 162K | +95% |
| Employees | 0 | — |
Legal name
JS-Med AB
Org number
5569377004
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 juli 2013
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva läkarpraktik, personaluthyrning inom sjuk- och företagshälsovård samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | — | 218 | 248 | 246 | 320 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 369 | 18 | 10 | −32 | 48 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 369 | 18 | 10 | −32 | 48 |
| Net financials | −1 | — | −7 | — | −5 |
| Profit before tax | 283 | 13 | 3 | 0 | 101 |
| Tax | −62 | −3 | −1 | −0 | −22 |
| Net profit | 221 | 10 | 2 | 0 | 79 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 636 | 468 | 424 | 443 | 497 |
| Equity | 290 | 81 | 83 | 83 | 162 |
| Long-term debt | 0 | 132 | 132 | 132 | 132 |
| Short-term debt | 261 | 165 | 119 | 170 | 204 |
| Total debt | 261 | 297 | 251 | 302 | 336 |
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
20152019
Equity ratio
32.6%
This company
38.2%
Market median
+15% vs market
20152019
Return on equity
48.8%
This company
18.4%
Market median
+165% vs market
20152019
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20152019
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20152019
Debt / equity
2.07×
This company
0.62×
Market median
-234% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IE Liquidator | Liquidator | 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JS-Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Irena Ewa Hägglund | Liquidator | 0 companies |
| Birgitta Gun-Marie Nordlander Smedberg | Deputy Board Member | 0 companies |
| Johan Bernhard Kenneth Smedberg | Board of Directors | 0 companies |